Microbix Biosystems Statistics

Total Valuation

Microbix Biosystems has a market cap or net worth of CAD 55.59 million. The enterprise value is 49.02 million.

Market Cap	55.59M
Enterprise Value	49.02M

Important Dates

The last earnings date was Friday, December 20, 2024.

Earnings Date	Dec 20, 2024
Ex-Dividend Date	n/a

Share Statistics

Microbix Biosystems has 135.59 million shares outstanding. The number of shares has decreased by -0.31% in one year.

Current Share Class	n/a
Shares Outstanding	135.59M
Shares Change (YoY)	-0.31%
Shares Change (QoQ)	-0.41%
Owned by Insiders (%)	15.66%
Owned by Institutions (%)	0.43%
Float	114.35M

Valuation Ratios

The trailing PE ratio is 15.92 and the forward PE ratio is 20.50.

PE Ratio	15.92
Forward PE	20.50
PS Ratio	2.21
PB Ratio	1.96
P/TBV Ratio	2.31
P/FCF Ratio	20.50
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.11, with an EV/FCF ratio of 18.08.

EV / Earnings	13.93
EV / Sales	1.93
EV / EBITDA	9.11
EV / EBIT	12.55
EV / FCF	18.08

Financial Position

The company has a current ratio of 7.15, with a Debt / Equity ratio of 0.23.

Current Ratio	7.15
Quick Ratio	5.05
Debt / Equity	0.23
Debt / EBITDA	1.19
Debt / FCF	2.36
Interest Coverage	4.24

Financial Efficiency

Return on equity (ROE) is 13.30% and return on invested capital (ROIC) is 7.40%.

Return on Equity (ROE)	13.30%
Return on Assets (ROA)	6.62%
Return on Capital (ROIC)	7.40%
Revenue Per Employee	253,941
Profits Per Employee	35,202
Employee Count	70
Asset Turnover	0.69
Inventory Turnover	1.64

Taxes

Income Tax	-5
Effective Tax Rate	-0.00%

Stock Price Statistics

The stock price has increased by +9.72% in the last 52 weeks. The beta is 0.34, so Microbix Biosystems's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+9.72%
50-Day Moving Average	0.33
200-Day Moving Average	0.34
Relative Strength Index (RSI)	70.02
Average Volume (20 Days)	92,340

Short Selling Information

The latest short interest is 11,447, so 0.01% of the outstanding shares have been sold short.

Short Interest	11,447
Short Previous Month	4,761
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microbix Biosystems had revenue of CAD 25.39 million and earned 3.52 million in profits. Earnings per share was 0.03.

Revenue	25.39M
Gross Profit	15.39M
Operating Income	3.91M
Pretax Income	3.67M
Net Income	3.52M
EBITDA	5.20M
EBIT	3.91M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 12.96 million in cash and 6.40 million in debt, giving a net cash position of 6.57 million or 0.05 per share.

Cash & Cash Equivalents	12.96M
Total Debt	6.40M
Net Cash	6.57M
Net Cash Per Share	0.05
Equity (Book Value)	28.30M
Book Value Per Share	0.21
Working Capital	20.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.35 million and capital expenditures -1.64 million, giving a free cash flow of 2.71 million.

Operating Cash Flow	4.35M
Capital Expenditures	-1.64M
Free Cash Flow	2.71M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 60.61%, with operating and profit margins of 15.38% and 13.86%.

Gross Margin	60.61%
Operating Margin	15.38%
Pretax Margin	14.46%
Profit Margin	13.86%
EBITDA Margin	20.49%
EBIT Margin	15.38%
FCF Margin	10.68%

Dividends & Yields

Microbix Biosystems does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.31%
Shareholder Yield	0.31%
Earnings Yield	6.28%
FCF Yield	4.88%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Microbix Biosystems has an Altman Z-Score of 3.32 and a Piotroski F-Score of 8.

Altman Z-Score	3.32
Piotroski F-Score	8